Phase II results suggest targeted therapy is effective for moderate to severe ulcerative colitis
Credit: New England Journal of Medicine (2024). DOI: 10.1056/NEJMoa2314076 An international placebo-controlled study led by Cedars-Sinai suggests that a targeted...
